| Title |
Outpatient parenteral antimicrobial therapy with ceftriaxone, a review
|
|---|---|
| Published in |
International Journal of Clinical Pharmacy, April 2012
|
| DOI | 10.1007/s11096-012-9637-z |
| Pubmed ID | |
| Authors |
Christopher J. A. Duncan, David A. Barr, R. Andrew Seaton |
| Abstract |
More than 30 years since it was developed for clinical use, the third-generation cephalosporin ceftriaxone remains the most commonly used agent for outpatient parental antimicrobial therapy (OPAT). Recent antimicrobial stewardship programmes have tended to restrict ceftriaxone use in hospitals to control antibiotic resistance and outbreaks of Clostridium difficle infection (CDI). Considering the expansion of OPAT programmes both in the UK and worldwide, revisiting the role of ceftriaxone in OPAT in the context of changing antimicrobial prescribing practices is timely. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| Unknown | 83 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 16 | 19% |
| Other | 12 | 14% |
| Researcher | 9 | 11% |
| Student > Postgraduate | 8 | 9% |
| Student > Master | 5 | 6% |
| Other | 16 | 19% |
| Unknown | 19 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 39% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 11% |
| Nursing and Health Professions | 6 | 7% |
| Agricultural and Biological Sciences | 4 | 5% |
| Immunology and Microbiology | 2 | 2% |
| Other | 8 | 9% |
| Unknown | 23 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2019.
All research outputs
#6,912,149
of 22,665,794 outputs
Outputs from International Journal of Clinical Pharmacy
#388
of 1,071 outputs
Outputs of similar age
#47,632
of 161,950 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#4
of 19 outputs
Altmetric has tracked 22,665,794 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,071 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,950 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.